Cigna Group (CI) Competitors $305.71 +3.28 (+1.08%) Closing price 03:59 PM EasternExtended Trading$305.80 +0.09 (+0.03%) As of 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CI vs. CNC, ELV, HCA, HUM, UNH, MOH, SEM, JYNT, AEMD, and NVOShould you be buying Cigna Group stock or one of its competitors? The main competitors of Cigna Group include Centene (CNC), Elevance Health (ELV), HCA Healthcare (HCA), Humana (HUM), UnitedHealth Group (UNH), Molina Healthcare (MOH), Select Medical (SEM), Joint (JYNT), Aethlon Medical (AEMD), and Novo Nordisk A/S (NVO). These companies are all part of the "medical" sector. Cigna Group vs. Its Competitors Centene Elevance Health HCA Healthcare Humana UnitedHealth Group Molina Healthcare Select Medical Joint Aethlon Medical Novo Nordisk A/S Cigna Group (NYSE:CI) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends. Which has preferable earnings & valuation, CI or CNC? Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCigna Group$254.47B0.32$3.43B$18.0616.93Centene$163.07B0.09$3.31B$6.714.53 Which has more volatility & risk, CI or CNC? Cigna Group has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Is CI or CNC more profitable? Centene has a net margin of 2.04% compared to Cigna Group's net margin of 1.97%. Cigna Group's return on equity of 18.63% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Cigna Group1.97% 18.63% 4.97% Centene 2.04%14.56%4.75% Do insiders and institutionals hold more shares of CI or CNC? 87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.7% of Cigna Group shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media favor CI or CNC? In the previous week, Centene had 62 more articles in the media than Cigna Group. MarketBeat recorded 87 mentions for Centene and 25 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.21 beat Centene's score of 0.09 indicating that Cigna Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 22 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 8 Very Positive mention(s) 5 Positive mention(s) 56 Neutral mention(s) 13 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer CI or CNC? Cigna Group currently has a consensus target price of $380.39, suggesting a potential upside of 24.43%. Centene has a consensus target price of $58.63, suggesting a potential upside of 92.88%. Given Centene's higher possible upside, analysts clearly believe Centene is more favorable than Cigna Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cigna Group 0 Sell rating(s) 2 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 3.00Centene 1 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.28 SummaryCigna Group beats Centene on 12 of the 16 factors compared between the two stocks. Get Cigna Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CI vs. The Competition Export to ExcelMetricCigna GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap$81.67B$40.30B$5.57B$20.65BDividend Yield1.99%82.03%4.23%3.65%P/E Ratio16.938.8828.6127.29Price / Sales0.321.37411.3153.19Price / Cash8.028.8336.0222.28Price / Book2.062.608.234.60Net Income$3.43B$2.64B$3.23B$995.22M7 Day Performance-1.22%-4.93%-0.01%-0.80%1 Month Performance-2.73%-13.69%5.60%3.55%1 Year Performance-10.03%-37.51%26.54%7.35% Cigna Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CICigna Group4.9888 of 5 stars$305.72+1.1%$380.39+24.4%-8.8%$81.67B$254.47B16.9373,500Positive NewsCNCCentene4.9701 of 5 stars$30.61-2.6%$64.75+111.5%-54.5%$15.23B$169.28B4.5660,500Trending NewsAnalyst ForecastHigh Trading VolumeELVElevance Health4.9581 of 5 stars$339.77-0.3%$491.07+44.5%-36.7%$76.77B$177.01B13.26104,200Trending NewsUpcoming EarningsAnalyst ForecastHCAHCA Healthcare4.9678 of 5 stars$380.43+1.2%$395.71+4.0%+17.3%$91.52B$71.59B16.92316,000Trending NewsAnalyst ForecastHUMHumana4.5749 of 5 stars$227.13-1.5%$280.76+23.6%-42.2%$27.41B$117.76B16.0665,680Analyst ForecastUNHUnitedHealth Group4.9963 of 5 stars$300.37-1.2%$415.00+38.2%-43.4%$272.48B$410.06B12.58400,000Trending NewsAnalyst ForecastMOHMolina Healthcare4.9895 of 5 stars$219.08-1.1%$352.21+60.8%-24.5%$11.87B$41.87B10.5818,000Upcoming EarningsAnalyst ForecastAnalyst RevisionSEMSelect Medical4.9993 of 5 stars$14.91+1.2%$26.00+74.3%-61.1%$1.92B$5.22B11.1344,100JYNTJoint3.5909 of 5 stars$11.45-1.3%$15.50+35.4%-20.6%$175.19M$51.90M-19.74320Positive NewsAEMDAethlon Medical1.9007 of 5 stars$1.15-2.5%$56.00+4,769.6%-64.5%$2.97MN/A-0.0910NVONovo Nordisk A/S4.2289 of 5 stars$68.920.0%$112.00+62.5%-52.4%$307.71B$42.12B20.3977,349Positive News Related Companies and Tools Related Companies Centene Alternatives Elevance Health Alternatives HCA Healthcare Alternatives Humana Alternatives UnitedHealth Group Alternatives Molina Healthcare Alternatives Select Medical Alternatives Joint Alternatives Aethlon Medical Alternatives Novo Nordisk A/S Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CI) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cigna Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Cigna Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CI Stock Alerts